Progression in idiopathic, diabetic, paraproteinemic, alcoholic, and B12 deficiency neuropathy
Identifieur interne : 000F51 ( Main/Exploration ); précédent : 000F50; suivant : 000F52Progression in idiopathic, diabetic, paraproteinemic, alcoholic, and B12 deficiency neuropathy
Auteurs : Shafina Sachedina [Irlande (pays)] ; Cory Toth [Canada]Source :
- Journal of the Peripheral Nervous System [ 1085-9489 ] ; 2013-09.
Abstract
We determined prospectively the clinical and electrophysiological progression of idiopathic, diabetic, paraproteinemic, alcoholic, and B12 deficiency neuropathy in 606 subjects over 3 years. We hypothesized that idiopathic peripheral neuropathy would demonstrate slower progression when compared with other etiologies. Laboratory assessments were used to determine the etiology of peripheral neuropathy at baseline and after 3 years. When compared with peripheral neuropathy related to type 1 or type 2 diabetes mellitus, subjects with idiopathic peripheral neuropathy progressed much slower, but demonstrated similar rates of progression to that of the other groups. Overall, detectable progression was minimal over 3 years. After 3 years, only 3% of cases of idiopathic peripheral neuropathy had any potentially identifiable causes discovered. Clinical and electrophysiological detection of very slow progression for these five types of peripheral neuropathy is possible using currently established clinical scales and standard electrophysiological techniques.
Url:
DOI: 10.1111/jns5.12042
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001B62
- to stream Istex, to step Curation: 001B62
- to stream Istex, to step Checkpoint: 000069
- to stream Main, to step Merge: 000F63
- to stream Main, to step Curation: 000F51
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Progression in idiopathic, diabetic, paraproteinemic, alcoholic, and B12 deficiency neuropathy</title><author><name sortKey="Sachedina, Shafina" sort="Sachedina, Shafina" uniqKey="Sachedina S" first="Shafina" last="Sachedina">Shafina Sachedina</name></author><author><name sortKey="Toth, Cory" sort="Toth, Cory" uniqKey="Toth C" first="Cory" last="Toth">Cory Toth</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:A3B65FCDF80B8B0E6124D80351E9B4A6C712C04A</idno><date when="2013" year="2013">2013</date><idno type="doi">10.1111/jns5.12042</idno><idno type="url">https://api-v5.istex.fr/document/A3B65FCDF80B8B0E6124D80351E9B4A6C712C04A/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001B62</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001B62</idno><idno type="wicri:Area/Istex/Curation">001B62</idno><idno type="wicri:Area/Istex/Checkpoint">000069</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000069</idno><idno type="wicri:doubleKey">1085-9489:2013:Sachedina S:progression:in:idiopathic</idno><idno type="wicri:Area/Main/Merge">000F63</idno><idno type="wicri:Area/Main/Curation">000F51</idno><idno type="wicri:Area/Main/Exploration">000F51</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Progression in idiopathic, diabetic, paraproteinemic, alcoholic, and B12 deficiency neuropathy</title><author><name sortKey="Sachedina, Shafina" sort="Sachedina, Shafina" uniqKey="Sachedina S" first="Shafina" last="Sachedina">Shafina Sachedina</name><affiliation wicri:level="1"><country xml:lang="fr">Irlande (pays)</country><wicri:regionArea>Royal College of Surgeons Ireland, School of Medicine, Dublin</wicri:regionArea><wicri:noRegion>Dublin</wicri:noRegion></affiliation></author><author><name sortKey="Toth, Cory" sort="Toth, Cory" uniqKey="Toth C" first="Cory" last="Toth">Cory Toth</name><affiliation wicri:level="4"><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Clinical Neurosciences and the Hotchkiss Brain Institute, University of Calgary, AB, Calgary</wicri:regionArea><orgName type="university">Université de Calgary</orgName><placeName><settlement type="city">Calgary</settlement><region type="state">Alberta</region></placeName></affiliation><affiliation wicri:level="1"><country wicri:rule="url">Canada</country></affiliation></author></analytic><monogr></monogr><series><title level="j">Journal of the Peripheral Nervous System</title><title level="j" type="abbrev">J Peripher Nerv Syst</title><idno type="ISSN">1085-9489</idno><idno type="eISSN">1529-8027</idno><imprint><publisher>Wiley Periodicals, Inc.</publisher><pubPlace>Malden, USA</pubPlace><date type="published" when="2013-09">2013-09</date><biblScope unit="volume">18</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="247">247</biblScope><biblScope unit="page" to="255">255</biblScope></imprint><idno type="ISSN">1085-9489</idno></series><idno type="istex">A3B65FCDF80B8B0E6124D80351E9B4A6C712C04A</idno><idno type="DOI">10.1111/jns5.12042</idno><idno type="ArticleID">JNS512042</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1085-9489</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract">We determined prospectively the clinical and electrophysiological progression of idiopathic, diabetic, paraproteinemic, alcoholic, and B12 deficiency neuropathy in 606 subjects over 3 years. We hypothesized that idiopathic peripheral neuropathy would demonstrate slower progression when compared with other etiologies. Laboratory assessments were used to determine the etiology of peripheral neuropathy at baseline and after 3 years. When compared with peripheral neuropathy related to type 1 or type 2 diabetes mellitus, subjects with idiopathic peripheral neuropathy progressed much slower, but demonstrated similar rates of progression to that of the other groups. Overall, detectable progression was minimal over 3 years. After 3 years, only 3% of cases of idiopathic peripheral neuropathy had any potentially identifiable causes discovered. Clinical and electrophysiological detection of very slow progression for these five types of peripheral neuropathy is possible using currently established clinical scales and standard electrophysiological techniques.</div></front></TEI><affiliations><list><country><li>Canada</li><li>Irlande (pays)</li></country><region><li>Alberta</li></region><settlement><li>Calgary</li></settlement><orgName><li>Université de Calgary</li></orgName></list><tree><country name="Irlande (pays)"><noRegion><name sortKey="Sachedina, Shafina" sort="Sachedina, Shafina" uniqKey="Sachedina S" first="Shafina" last="Sachedina">Shafina Sachedina</name></noRegion></country><country name="Canada"><region name="Alberta"><name sortKey="Toth, Cory" sort="Toth, Cory" uniqKey="Toth C" first="Cory" last="Toth">Cory Toth</name></region><name sortKey="Toth, Cory" sort="Toth, Cory" uniqKey="Toth C" first="Cory" last="Toth">Cory Toth</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F51 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000F51 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:A3B65FCDF80B8B0E6124D80351E9B4A6C712C04A
|texte= Progression in idiopathic, diabetic, paraproteinemic, alcoholic, and B12 deficiency neuropathy
}}
| This area was generated with Dilib version V0.6.29. |  |